Latest Stock/Share Market Updates | Corporate News | Announcements | BSE
Notices Media Release Trading Holidays BSEPlus Contact Us
हिन्दी     मराठी     ગુજરાતી


Latest Corporate Announcements

Announcement Type :   Search By :    
Security Name
Category
Date Calendar
To Date Calendar
Disclaimer  Next >>
   
Security Code : 532488    Company : DIVI'S LABORATORIES LTD.
16 Oct 2017
Compliance Certificate For The Half Year Ended 30Th September, 2017Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  16/10/2017 15:08:05         Exchange Disseminated Time   16/10/2017 15:08:11              Time Taken   00:00:06
Please find enclosed Compliance Certificate as required under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended 30th September 2017.
 
10 Oct 2017
Shareholding for the Period Ended September 30, 2017Company Update 
  Exchange Disseminated Time     10/10/2017 14:36:34
Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here
 
09 Oct 2017
Compliance Certificate For The Period Ended 30Th September, 2017Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  09/10/2017 12:24:05         Exchange Disseminated Time   09/10/2017 12:24:10              Time Taken   00:00:05

We enclose herewith Compliance Certificate certifying compliance with the requirements of sub-regulation (2), from the Company and the Registrar and Share Transfer Agent for half year ended 30th September 2017
 
  Statement Of Investor Complaints For The Quarter Ended 30Th September, 2017Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  09/10/2017 12:18:13         Exchange Disseminated Time   09/10/2017 12:18:18              Time Taken   00:00:05

In compliance with Regulation 13(3) of SEBI (LODR) Regulations, 2015, please find below the statement of investors complaints for the quarter ended 30th September, 2017:

SI.No. Particulars Number
1 Number of complaints pending at the beginning of the quarter Nil
2 Number of complaints received during the quarter 11 ....
26 Sep 2017
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)AGM/EGM 
  Exchange Disseminated Time     26/09/2017 15:06:33
Divis Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
 
  Scrutinizer's ReportAGM/EGMDownload PDFDownload XBRL
  Exchange Received Time  26/09/2017 14:40:46         Exchange Disseminated Time   26/09/2017 14:40:50              Time Taken   00:00:04
Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, details of voting results of 27th Annual General Meeting (AGM) of the Company held on 25th September 2017 at 10.00 a.m. at Global Peace Auditorium, Brahma Kumaris, Shanti Sarovar, Academy for Better World, Gachibowli, Hyderabad - 500 032, are enclosed as per prescribed format. ....
25 Sep 2017
Chairman's SpeechAGM/EGMDownload PDFDownload XBRL
  Exchange Received Time  25/09/2017 17:01:44         Exchange Disseminated Time   25/09/2017 17:01:46              Time Taken   00:00:02
Further to our communication dated 25th September, 2017, please find attached herewith copy of Chairman's Speech delivered at the 27th Annual General Meeting (AGM) of the Company held on 25th September 2017 at 10.00 a.m. at Global Peace Auditorium, Brahma Kumaris, Shanti Sarovar, Academy for Better World, Gachibowli, Hyderabad - 500 032.
 
  Outcome of AGMAGM/EGMDownload PDFDownload XBRL
  Exchange Received Time  25/09/2017 15:16:40         Exchange Disseminated Time   25/09/2017 15:16:46              Time Taken   00:00:06
The 27th AGM of the Company was held on September 25, 2017 at 10.00 a.m. at Global Peace Auditorium, Brahma Kumaris, Shanti Sarovar, Academy for Better World, Gachibowli, Hyderabad - 500 032.

We are enclosing herewith Summary of the proceedings of the AGM of the Company as required under Regulation 30, Part-1 of Schedule-III of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( 'the Listing Regulations'). ....
20 Sep 2017
  UpdatesCompany UpdateDownload PDFDownload XBRL
  Exchange Received Time  20/09/2017 10:33:51         Exchange Disseminated Time   20/09/2017 10:33:55              Time Taken   00:00:04
We wish to inform that Divi's Laboratories Limited, Unit-2 has been inspected by US-FDA from September 11 to September 19, 2017.

This inspection was for full cGMP and verification of all Corrective Actions proposed against the previous Inspection observations. Divi's Laboratories Limited announces that all previous observations have been confirmed as completed and resolved. ....
30 Aug 2017
UpdatesCompany UpdateDownload PDFDownload XBRL
  Exchange Received Time  30/08/2017 10:24:56         Exchange Disseminated Time   30/08/2017 10:25:02              Time Taken   00:00:06
We enclose herewith Notice of the 27th Annual General Meeting of the Company scheduled to be held on Monday, the 25th day of September 2017 at 10.00 A.M. at Global Peace Auditorium, Brahma Kumaris, Shanti Sarovar, Academy for Better World, Gachibowli, Hyderabad - 500 032.
 
22 Aug 2017
Fixes Book Closure for Dividend & AGMAGM/EGMDownload PDF
  Exchange Disseminated Time     22/08/2017 12:39:48
Divis Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 19, 2017 to September 25, 2017 (both days inclusive) for the purpose of Payment of Dividend & 27th Annual General Meeting (AGM) of the Company to be held on September 25, 2017.

The dividend, if declared at the Annual General Meeting, will be credited / dispatched on or before October 10, 2017.
 
21 Aug 2017
  Fixes Book Closure For Annual General Meeting And DividendCorp. ActionDownload PDFDownload XBRL
  Exchange Received Time  21/08/2017 11:26:08         Exchange Disseminated Time   21/08/2017 11:26:17              Time Taken   00:00:09
We hereby inform you that 27th Annual General Meeting (AGM) of the members of the company will be held on Monday, the 25th day of September 2017 at 10.00 A.M. at Global Peace Auditorium, Brahma Kumaris, Shanti Sarovar, Academy for Better World, Gachibowli, Hyderabad - 500 032.

The Register of Members and Share Transfer Books of the Company will remain closed from Tuesday, September 19, 2017 to Monday, September 25, 2017 (both days inclusive) ....
04 Aug 2017
UpdatesCompany UpdateDownload PDFDownload XBRL
  Exchange Received Time  04/08/2017 14:37:19         Exchange Disseminated Time   04/08/2017 14:37:24              Time Taken   00:00:05
Divi's Laboratories Limited, Unit-2 Vishakhapatnam has been inspected by 5 inspectors from HPRA (Ireland) and JAZMP (Slovenia) from 31st July 2017 to 4th August 2017.

The inspection was focused on:

1)Follow up on the effectiveness of the CAPA's implemented from the last JAZMP inspection
2)General GMP inspection of the site
The inspection has concluded successfully with no critical observations.

 
22 Jul 2017
Outcome of Board MeetingBoard MeetingDownload PDFDownload XBRL
  Exchange Received Time  22/07/2017 15:28:50         Exchange Disseminated Time   22/07/2017 15:28:57              Time Taken   00:00:07
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors at its meeting held on 22nd July, 2017 has appointed Dr. S. Ganapaty as an Additional (Independent) Director w.e.f. 22nd July, 2017.
 
  Un-Audited Financial Results For The Quarter Ended 30.06.2017ResultDownload PDFDownload XBRL
  Exchange Received Time  22/07/2017 13:49:51         Exchange Disseminated Time   22/07/2017 13:49:56              Time Taken   00:00:05
Further to our letter dated 14th July, 2017, we would like to inform that the Board of Directors of the Company at its meeting held on Saturday, 22nd July 2017 has approved Un-audited Financial Results for the first quarter ended 30th June, 2017.

In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we are enclosing herewith the following: ....
17 Jul 2017
Shareholding for the Period Ended June 30, 2017Company Update 
  Exchange Disseminated Time     17/07/2017 12:26:10
Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here
 
14 Jul 2017
   Meeting Of Board Of Directors Of The Company To Be Held On Saturday, The 22Nd Day Of July 2017Board MeetingDownload PDFDownload XBRL
  Exchange Received Time  14/07/2017 13:16:25         Exchange Disseminated Time   14/07/2017 13:16:33              Time Taken   00:00:08
Notice is hereby given that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, the 22nd day of July 2017, inter-alia, to consider and approve un-audited financial results for the quarter ended 30th June 2017.

We further inform you that the Trading Window for dealing in securities of the Company shall remain closed for insiders of the company from 15th July, 2017 to 24th July, 2017 (both days inclusive) ....
13 Jul 2017
  Statement Showing The Investor Complaints For The Quarter Ended 30Th June, 2017Company UpdateDownload PDFDownload XBRL
  Exchange Received Time  13/07/2017 14:04:57         Exchange Disseminated Time   13/07/2017 14:04:59              Time Taken   00:00:02
In compliance with Regulation 13(3) of SEBI (LODR) Regulations, 2015, please find below the statement of investors complaints for the quarter ended 30th June, 2017:

SI.No. Particulars Number
1 Number of complaints pending at the beginning of the quarter Nil
2 Number of complaints received during the quarter 1 ....
11 Jul 2017
  UpdatesCompany UpdateDownload PDFDownload XBRL
  Exchange Received Time  11/07/2017 14:13:56         Exchange Disseminated Time   11/07/2017 14:14:06              Time Taken   00:00:10
Sub: Discrepancies in Financial Result of the Company for the Quarter /Year ended March 2017

Ref : 1. SEBI circular ref No. CIR/CFD/FAC/62/2016 dated July 05, 2016
2. Your email dated 10th July, 2017


With reference to the above, please find attached herewith the declaration/undertaking on the audited standalone and consolidated financial results of the Company duly signed for the year ended 31st March 2017. ....
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Insider Trading / SASTDownload PDF
  Exchange Disseminated Time     11/07/2017 10:37:39
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers)Regulations, 2011 for SBI Funds Management Pvt Ltd
 

Disclaimer Next >>